Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Moodys
Johnson and Johnson
Mallinckrodt
Merck
Boehringer Ingelheim

Last Updated: November 21, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Zinc gluconate

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Zinc gluconate?

Zinc gluconate is an investigational drug.

There have been 14 clinical trials for Zinc gluconate. The most recent clinical trial was a Phase 3 trial, which was initiated on November 1st 2011.

The most common disease conditions in clinical trials are Diarrhea, Pneumonia, and Herpes Labialis. The leading clinical trial sponsors are All India Institute of Medical Sciences, New Delhi, Society for Applied Studies, and Chang Gung Memorial Hospital.

There is one US patent protecting this investigational drug and nine international patents.

Recent Clinical Trials for Zinc gluconate
TitleSponsorPhase
Zinc Sulfate AcceptabilityInternational Centre for Diarrhoeal Disease Research, BangladeshN/A
The Individual Therapy for Patients With Wilson's DiseaseSecond Affiliated Hospital, School of Medicine, Zhejiang UniversityEarly Phase 1
Zinc Supplement in Regorafenib Treated mCRC PatientChang Gung Memorial HospitalPhase 2

See all Zinc gluconate clinical trials

Clinical Trial Summary for Zinc gluconate

Top disease conditions for Zinc gluconate
Top clinical trial sponsors for Zinc gluconate

See all Zinc gluconate clinical trials

US Patents for Zinc gluconate

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Zinc gluconate   Start Trial Methods and compositions for use with gel dispensers GOJO Industries, Inc. (Akron, OH)   Start Trial
Zinc gluconate   Start Trial Dentifrice compositions containing extracts of Nigella sativa and related methods Health and Natural Beauty USA Corp. (New Brunswick, NJ)   Start Trial
Zinc gluconate   Start Trial Compositions for oral administration of zoledronic acid or related compounds for treating complex regional pain syndrome ANTECIP BIOVENTURES II LLC (New York, NY)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
Harvard Business School
Baxter
McKesson
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.